Apoptosis of HIV-specific CD8 + T cells: An HIV evasion strategy

Cell Death and Differentiation

Volumn 12, Issue , 2005, Pages 859-870

  Petrovas, C ^a   Mueller, Y M ^a   Katsikis, P D ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD28 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; PADGEM PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEINASE INHIBITOR; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN; VPR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; APOPTOSIS; CELL SURVIVAL; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DRUG EFFICACY; DRUG POTENCY; DRUG RESPONSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VACCINATION; VIRUS IMMUNITY; VIRUS INHIBITION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE;

AIDS VACCINES; ANIMALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOKINES; GENE EXPRESSION REGULATION; GENES, BCL-2; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; RETROVIRIDAE PROTEINS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 22744448560     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401595     Document Type: Article

References (215)

1. Douek DC et al. (2003) Annu. Rev. Immunol. 21: 265-304
2. Borrow P et al. (1997) Nat. Med. 3: 205-211
3. Gandhi RT and Walker BD (2002) Annu. Rev. Med. 53: 149-172
4. McMichael AJ and Hanke T (2003) Nat. Med. 9: 874-880
5. McMichael AJ et al. (1983) N. Engl. J. Med. 309: 13-17
6. Koup RA et al. (1994) J. Virol. 68: 4650-4655
7. Walker CM et al. (1986) Science 234: 1563-1566
8. Walker BD et al. (1987) Nature 328: 345-348
9. Plata F et al. (1987) Nature 328: 348-351
10. Pantaleo G et al. (1994) Nature 370: 463-467
11. Ogg GS et al. (1998) Science 279: 2103-2106
12. Moss PA et al. (1995) Proc. Natl. Acad. Sci. USA 92: 5773-5777
13. Altman JD et al. (1996) Science 274: 94-96
14. Wilson JD et al. (1998) J. Exp. Med. 188: 785-790
15. Borrow P et al. (1994) J. Virol. 68: 6103-6110
16. Cao Y et al. (1995) N. Engl. J. Med. 332: 201-208
17. Oxenius A et al. (2004) J. Infect. Dis. 189: 1199-1208
18. Oxenius A et al. (2004) J. Infect. Dis. 190: 713-721
19. Barouch DH et al. (2002) Nature 415: 335-339
20. Schmitz JE et al. (1999) Science 283: 857-860
21. Jin X et al. (1999) J. Exp. Med. 189: 991-998
22. Gray CM et al. (1999) J. Immunol. 162: 1780-1788
23. Kalams SA et al. (1999) J. Virol. 73: 6721-6728
24. Oxenius A et al. (2002) J. Clin. Immunol. 22: 363-374
25. Hess C et al. (2004) Lancet 363: 863-866
26. Estaquier J et al. (1995) J. Exp. Med. 182: 1759-1767
27. Katsikis PD et al. (1995) J. Exp. Med. 181: 2029-2036
28. Moretti S et al. (2000) Clin. Exp. Immunol. 122: 364-373
29. Gougeon ML (2003) Nat. Rev. Immunol. 3: 392-404
30. Meyaard L et al. (1992) Science 257: 217-219
31. Gougeon ML et al. (1993) AIDS Res. Hum. Retroviruses 9: 553-563
32. Estaquier J et al. (1994) Proc. Natl. Acad. Sci. USA 91: 9431-9435
33. Katsikis PD et al. (1997) J. Exp. Med. 186: 1365-1372
34. Finkel TH et al. (1995) Nat. Med. 1: 129-134
35. Herbein G et al. (1998) J. Virol. 72: 660-670
36. Rosok BI et al. (1998) AIDS Res. Hum. Retroviruses 14: 1635-1643
37. Muro-Cacho CA, Pantaleo G and Fauci AS (1995) J. Immunol. 154: 5555-5566
38. Wei X et al. (1995) Nature 373: 117-122
39. McCune JM (2001) Nature 410: 974-979
40. Grossman Z et al. (2002) Nat. Med. 8: 319-323
41. Gloster SE et al. (2004) AIDS 18: 749-755
42. Ho DD et al. (1995) Nature 373: 123-126
43. Lenardo MJ et al. (2002) J. Virol. 76: 5082-5093
44. Rosenberg YJ and Janossy G (1999) Semin. Immunol. 11: 139-154
45. Wang L et al. (1999) J. Immunol. 162: 268-276
46. Hazenberg MD et al. (2000) Nat. Immunol. 1: 285-289
47. Simmons A, Aluvihare V and McMichael A (2001) Immunity 14: 763-777
48. Yu Q et al. (2003) J. Immunol. 170: 1797-1805
49. Carbonneil C et al. (2003) AIDS 17: 1731-1740
50. Banda NK et al. (1992) J. Exp. Med. 176: 1099-1106
51. Li CJ et al. (1995) Science 268: 429-431
52. Mueller YM et al. (2003) Int. Immunol. 15: 49-58
53. Samuelsson A et al. (1997) Virology 238: 180-188
54. Prati E et al. (1997) AIDS Res. Hum. Retroviruses 13: 1501-1508
55. Liegler TJ et al. (1998) J. Infect. Dis. 178: 669-679
56. Grelli S et al. (2003) Ann. NY Acad. Sci. 1010: 560-564
57. Badley AD et al. (1999) Cell Death Differ. 6: 420-432
58. Bohler T et al. (1999) AIDS 13: 779-789
59. Monceaux V et al. (2003) AIDS 17: 1585-1596
60. de Oliveira Pinto LM et al. (2002) Blood 99: 1666-1675
61. Mueller YM et al. (2001) Immunity 15: 871-882
62. Arnoult D et al. (2003) Cell Death Differ. 10: 1240-1252
63. Xu XN et al. (1997) J. Exp. Med. 186: 7-16
64. Piazza C et al. (1997) J. Immunol. 158: 1503-1506
65. Tateyama M et al. (2000) Blood 96: 195-202
66. Esser MT et al. (2001) J. Virol. 75: 1152-1164
67. Geleziunas R et al. (2001) Nature 410: 834-838
68. Badley AD et al. (1996) J. Virol. 70: 199-206
69. Dockrell DH et al. (1998) J. Clin. Invest. 101: 2394-2405
70. Xu XN et al. (1999) J. Exp. Med. 189: 1489-1496
71. Herbein G et al. (1998) Nature 395: 189-194
72. Raftery MJ et al. (2001) Immunity 15: 997-1009
73. Appay V et al. (2002) J. Immunol. 168: 3660-3666
74. Oxenius A et al. (2001) Eur. J. Immunol. 31: 1115-1121
75. Oxenius A et al. (2000) Proc. Natl. Acad. Sci. USA 97: 3382-3387
76. Ogg GS et al. (1999) J. Virol. 73: 797-800
77. Mohri H et al. (1998) Science 279: 1223-1227
78. Rosenzweig M et al. (1998) Proc. Natl. Acad. Sci. USA 95: 6388-6393
79. Mohri H et al. (2001) J. Exp. Med. 194: 1277-1287
80. Hellerstein M et al. (1999) Nat. Med. 5: 83-89
81. Kovacs JA et al. (2001) J. Exp. Med. 194: 1731-1741
82. Gougeon ML et al. (1996) J. Immunol. 156: 3509-3520
83. Zaunders JJ et al. (2003) J. Infect. Dis. 187: 1735-1747
84. Silvestri G et al. (2003) Immunity 18: 441-452
85. Cannavo G et al. (2001) Blood 97: 1756-1764
86. Paiardini M et al. (2004) Immunol. Res. 29: 253-268
87. Paiardini M et al. (2004) AIDS 18: 393-402
88. Chun TW et al. (2004) Proc. Natl. Acad. Sci. USA 101: 2464-2469
89. Brenchley JM et al. (2003) Blood 101: 2711-2720
90. Singer GG and Abbas AK (1994) Immunity 1: 365-371
91. Cossarizza A et al. (2000) AIDS 14: 345-355
92. Moskophidis D, Laine E and Zinkernagel RM (1993) Eur. J. Immunol. 23: 3306-3311
93. Moskophidis D et al. (1993) Nature 362: 758-761
94. Zhou S et al. (2002) J. Virol. 76: 829-840
95. Zhou S et al. (2004) J. Virol. 78: 3578-3600
96. Pantaleo G et al. (1991) Proc. Natl. Acad. Sci. USA 88: 9838-9842
97. Masopust D et al. (2001) Science 291: 2413-2417
98. Wang XZ et al. (2003) Immunity 18: 631-642
99. Douek DC et al. (2002) Nature 417: 95-98
100. Trimble LA et al. (2000) Blood 96: 1021-1029
101. Geertsma MF et al. (1999) J. Infect. Dis. 180: 649-658
102. Lloyd TE et al. (1997) J. Immunol. 158: 1551-1558
103. Trimble LA and Lieberman J (1998) Blood 91: 585-594
104. Gamberg J et al. (2004) Immunol. Cell Biol. 82: 38-46
105. Topp MS et al. (2003) J. Exp. Med. 198: 947-955
106. Trimble LA et al. (2000) J. Virol. 74: 7320-7330
107. Leist TP et al. (1987) J. Immunol. 138: 2278-2281
108. Matloubian M et al. (1994) J. Virol. 68: 8056-8063
109. von Herrath MG et al. (1996) J. Virol. 70: 1072-1079
110. Janssen EM et al. (2003) Nature 421: 852-856
111. Schoenberger SP et al. (1998) Nature 393: 480-483
112. Vella AT et al. (1998) Proc. Natl. Acad. Sci. USA 95: 3810-3815
113. Klein MR et al. (1995) J. Exp. Med. 181: 1365-1372
114. Rosenberg ES et al. (1997) Science 278: 1447-1450
115. Iyasere C et al. (2003) J. Virol. 77: 10900-10909
116. Kalams SA et al. (1999) J. Virol. 73: 6715-6720
117. Ostrowski MA et al. (2000) J. Immunol. 165: 6133-6141
118. Gea-Banacloche JC et al. (2000) J. Immunol. 165: 1082-1092
119. Papagno L et al. (2002) Clin. Exp. Immunol. 130: 509-517
120. Betts MR et al. (2001) J. Virol. 75: 11983-11991
121. Kalams SA and Walker BD (1998) J. Exp. Med. 188: 2199-2204
122. Bevan MJ (2004) Nat. Rev. Immunol. 4: 595-602
123. Selliah N and Finkel TH (2001) Cell. Death Differ. 8: 127-136
124. Vlahakis SR et al. (2001) J. Clin. Invest. 107: 207-215
125. Algeciras-Schimnich A et al. (2002) AIDS 16: 1467-1478
126. Decrion AZ et al. (2004) J. Gen. Virol. 85: 1471-1478
127. Penn ML et al. (1999) Proc. Natl. Acad. Sci. USA 96: 663-668
128. Katsikis PD et al. (1997) Int. Immunol. 9: 835-841
129. Ferri KF et al. (2000) Ann. NY Acad. Sci. 926: 149-164
130. Jacotot E et al. (2001) J. Exp. Med. 193: 509-519
131. Imami N et al. (2002) J. Virol. 76: 9011-9023
132. Paiardini M et al. (2001) J. Virol. 75: 10843-10855
133. Adachi Y et al. (1996) J. Immunol. 157: 4184-4193
134. Estaquier J et al. (1996) Blood 87: 4959-4966
135. Naora H and Gougeon ML (1999) Cell Death Differ. 6: 1002-1011
136. Mueller YM et al. (2003) Blood 101: 1024-1029
137. Chehimi J et al. (1997) J. Immunol. 158: 5978-5987
138. Clerici M and Shearer GM (1994) Immunol. Today 15: 575-581
139. Ledru E et al. (1998) J. Immunol. 160: 3194-3206
140. Pericle F et al. (1998) J. Immunol. 160: 28-31
141. Kryworuchko M et al. (2004) AIDS 18: 421-426
142. MacPherson PA et al. (2001) J. Acquir. Immune Defic. Syndr. 28: 454-457
143. Marchetti G et al. (2004) Antivir. Ther. 9: 447-452
144. Westendorp MO et al. (1995) Nature 375: 497-500
145. Quaranta MG et al. (2004) FASEB J. 18: 1459-1461
146. Ahr B et al. (2004) Retrovirology 1: 1-12
147. Krammer PH (2000) Nature 407: 789-795
148. Peter ME and Krammer PH (2003) Cell Death Differ. 10: 26-35
149. Cory S and Adams JM (2002) Nat. Rev. Cancer 2: 647-656
150. Scaffidi C et al. (1998) EMBO J. 17: 1675-1687
151. Petrovas C et al. (2004) J. Immunol. 172: 4444-4453
152. Chao DT et al. (1995) J. Exp. Med. 182: 821-828
153. Thompson CB (1995) Science 267: 1456-1462
154. Boudet F, Lecoeur H and Gougeon ML (1996) J. Immunol. 156: 2282-2293
155. Blair PJ et al. (1997) J. Clin. Immunol. 17: 234-246
156. Hildeman DA et al. (2003) Proc. Natl. Acad. Sci. USA 100: 15035-15040
157. Macho A et al. (1995) Blood 86: 2481-2487
158. Papagno L et al. (2004) PLoS Biol. 2: 173-185
159. Borner C (1996) J. Biol. Chem. 271: 12695-12698
160. Linette GP et al. (1996) Proc. Natl. Acad. Sci. USA 93: 9545-9552
161. Bonnefoy-Berard N et al. (2004) Biochim. Biophys. Acta 1644: 159-168
162. Groux H et al. (1992) J. Exp. Med. 175: 331-340
163. Cossarizza A et al. (1997) AIDS 11: 19-26
164. Badley AD et al. (2003) Trends Pharmacol. Sci. 24: 298-305
165. Haeffner A et al. (1999) Eur. J. Immunol. 29: 334-344
166. Sun XM et al. (2002) J. Biol. Chem. 277: 11345-11351
167. Petit F et al. (2003) Biochimie 85: 795-811
168. Rippo MR et al. (2000) FASEB J. 14: 2047-2054
169. De Simone C et al. (1996) AIDS 10: 675-676
170. De Simone C et al. (1996) Immunol. Today 17: 48
171. Luo X et al. (1998) Cell 94: 481-490
172. Fackler OT and Baur AS (2002) Immunity 16: 493-497
173. Goulder PJ and Watkins DI (2004) Nat. Rev. Immunol. 4: 630-640
174. Thomsen AR et al. (2003) Immunol. Lett. 85: 119-127
175. Hamann D et al. (1997) J. Exp. Med. 186: 1407-1418
176. Sallusto F et al. (1999) Nature 401: 708-712
177. Tussey L et al. (2000) Eur. J. Immunol. 30: 1823-1829
178. Baars PA et al. (2000) J. Immunol. 165: 1910-1917
179. Franco A et al. (2000) Nat. Immunol. 1: 145-150
180. Manjunath N et al. (2001) J. Clin. Invest. 108: 871-878
181. Champagne P et al. (2001) Nature 410: 106-111
182. Chen G et al. (2001) Blood 98: 156-164
183. Kuroda MJ et al. (1999) J. Virol. 73: 1573-1579
184. Kuroda MJ et al. (2000) Blood 96: 1474-1479
185. Harty JT et al. (2000) Annu. Rev. Immunol. 18: 275-308
186. Kagi D et al. (1996) Annu. Rev. Immunol. 14: 207-232
187. Betts MR et al. (2000) J. Virol. 74: 9144-9151
188. Valitutti S et al. (1996) J. Exp. Med. 183: 1917-1921
189. Betts MR et al. (2004) J. Immunol. 172: 6407-6417
190. Koup RA et al. (1989) Blood 73: 1909-1914
191. Riviere Y et al. (1989) J. Virol. 63: 2270-2277
192. Lichterfeld M et al. (2004) Blood 104: 487-494
193. Shankar P et al. (2000) Blood 96: 3094-3101
194. Appay V et al. (2000) J. Exp. Med. 192: 63-75
195. Lieberman J et al. (2002) Curr. Opin. Immunol. 14: 478-486
196. Tanner JE and Alfieri C (1999) Blood 94: 3439-3447
197. Trabattoni D et al. (2004) AIDS 18: 859-869
198. Shacklett BL et al. (2004) J. Immunol. 173: 641-648
199. Stevceva L et al. (2004) Virology 319: 190-200
200. Goulder PJ et al. (2000) J. Exp. Med. 192: 1819-1832
201. Islam SA et al. (2001) J. Virol. 75: 4907-4911
202. Ullum H et al. (1997) AIDS Res. Hum. Retroviruses 13: 1039-1046
203. Bailer RT et al. (1999) J. Immunol. 162: 7534-7542
204. Benito JM et al. (2003) J. Acquir. Immune Defic. Syndr. 34: 255-266
205. Ince MN et al. (2004) Immunology 112: 531-542
206. Wagner L et al. (1998) Nature 391: 908-911
207. Heintel T et al. (2002) AIDS 16: 1497-1501
208. Hoffenbach A et al. (1989) J. Immunol. 142: 452-462
209. Koup RA et al. (1991) J. Exp. Med. 174: 1593-1600
210. Carmichael A et al. (1993) J. Exp. Med. 177: 249-256
211. Murali-Krishna K et al. (1998) Immunity 8: 177-187
212. Tan LC et al. (1999) J. Immunol. 162: 1827-1835
213. McMichael AJ and Phillips RE (1997) Annu. Rev. Immunol. 15: 271-296
214. O’Connor D et al. (2001) Immunol. Rev. 183: 115-126
215. Grakoui A et al. (2003) Science 302: 659-662